当前位置: X-MOL 学术Chemosphere › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Coronavirus and its terrifying inning around the globe: The pharmaceutical cares at the main frontline
Chemosphere ( IF 8.1 ) Pub Date : 2021-02-16 , DOI: 10.1016/j.chemosphere.2021.129968
Muneeb Ullah 1 , Abdul Wahab 1 , Sumbul Saeed 2 , Shahid Ullah Khan 2 , Haider Ali 1 , Shah Humayun 3 , Banzeer Ahsan Abbasi 4 , Shah Saud 5 , Khalid Naveed 6 , Sher Aslam Khan 7 , Shah Fahad 6
Affiliation  

A novel coronavirus (2019-nCoV) is an acute life-threatening disease, emerged in China, which imposed a potentially immense toll in terms of public health emergency due to high infection rate and has a devastating economic impact that attracts the world’s attention. After that, on January 30, 2020, it was officially declared as a global pandemic by World Health Organization (WHO). The International Committee on Taxonomy of Viruses (ICTV) recognized it as a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and the disease named Coronavirus Disease-19 (COVID-19). Several studies have been ameliorated the active role of COVID-19 transmission, etiology, pathogenicity, and mortality rate as serious impact on human life. The symptoms of this disease may include fever, fatigue, cough and some peoples are severely prone to gastrointestinal infection. The elderly and seriously affected peoples are likely concerned with serious outcomes. In this review, we mainly aimed to provide a benchmark summary of the silent characteristics and findings of some candidates for antiviral drugs and immunotherapies such as plasma therapy, cytokine therapy, antibodies, intravenous immunoglobulin, and pharmaceutical health concerns that are related to this disease.

更新日期:2021-02-28
down
wechat
bug